A Balanced Proinflammatory and Regulatory Cytokine Signature in Young African Children Is Associated With Lower Risk of Clinical Malaria
- PMID: 30380038
- PMCID: PMC7675332
- DOI: 10.1093/cid/ciy934
A Balanced Proinflammatory and Regulatory Cytokine Signature in Young African Children Is Associated With Lower Risk of Clinical Malaria
Abstract
Background: The effect of timing of exposure to first Plasmodium falciparum infections during early childhood on the induction of innate and adaptive cytokine responses and their contribution to the development of clinical malaria immunity is not well established.
Methods: As part of a double-blind, randomized, placebo-controlled trial in Mozambique using monthly chemoprophylaxis with sulfadoxine-pyrimethamine plus artesunate to selectively control timing of malaria exposure during infancy, peripheral blood mononuclear cells collected from participants at age 2.5, 5.5, 10.5, 15, and 24 months were stimulated ex vivo with parasite schizont and erythrocyte lysates. Cytokine messenger RNA expressed in cell pellets and proteins secreted in supernatants were quantified by reverse-transcription quantitative polymerase chain reaction and multiplex flow cytometry, respectively. Children were followed up for clinical malaria from birth until 4 years of age.
Results: Higher proinflammatory (interleukin [IL] 1, IL-6, tumor necrosis factor) and regulatory (IL-10) cytokine concentrations during the second year of life were associated with reduced incidence of clinical malaria up to 4 years of age, adjusting by chemoprophylaxis and prior malaria exposure. Significantly lower concentrations of antigen-specific T-helper 1 (IL-2, IL-12, interferon-γ) and T-helper 2 (IL-4, IL-5) cytokines by 2 years of age were measured in children undergoing chemoprophylaxis compared to children receiving placebo (P < .03).
Conclusions: Selective chemoprophylaxis altering early natural exposure to malaria blood stage antigens during infancy had a significant effect on T-helper lymphocyte cytokine production >1 year later. Importantly, a balanced proinflammatory and anti-inflammatory cytokine signature, probably by innate cells, around age 2 years was associated with protective clinical immunity during childhood.
Clinical trials registration: NCT00231452.
Keywords: Plasmodium falciparum; age; cytokines; exposure; immunity.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Figures
Similar articles
-
Impact of age of first exposure to Plasmodium falciparum on antibody responses to malaria in children: a randomized, controlled trial in Mozambique.Malar J. 2014 Mar 27;13:121. doi: 10.1186/1475-2875-13-121. Malar J. 2014. PMID: 24674654 Free PMC article. Clinical Trial.
-
Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican children.BMC Immunol. 2012 Jan 26;13:5. doi: 10.1186/1471-2172-13-5. BMC Immunol. 2012. PMID: 22280502 Free PMC article. Clinical Trial.
-
The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial.PLoS One. 2012;7(3):e32362. doi: 10.1371/journal.pone.0032362. Epub 2012 Mar 7. PLoS One. 2012. PMID: 22412865 Free PMC article. Clinical Trial.
-
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.Lancet. 2009 Oct 31;374(9700):1533-42. doi: 10.1016/S0140-6736(09)61258-7. Epub 2009 Sep 16. Lancet. 2009. PMID: 19765816 Review.
-
Pathogenesis of malaria and clinically similar conditions.Clin Microbiol Rev. 2004 Jul;17(3):509-39, table of contents. doi: 10.1128/CMR.17.3.509-539.2004. Clin Microbiol Rev. 2004. PMID: 15258091 Free PMC article. Review.
Cited by
-
Beta vulgaris Betalains Mitigate Parasitemia and Brain Oxidative Stress Induced by Plasmodium berghei in Mice.Pharmaceuticals (Basel). 2024 Aug 13;17(8):1064. doi: 10.3390/ph17081064. Pharmaceuticals (Basel). 2024. PMID: 39204168 Free PMC article.
-
Mature beyond their years: young children who escape detection of parasitemia despite living in settings of intense malaria transmission.Biochem Soc Trans. 2024 Jun 26;52(3):1025-1034. doi: 10.1042/BST20230401. Biochem Soc Trans. 2024. PMID: 38752830 Free PMC article. Review.
-
Artemisia spp.: An Update on Its Chemical Composition, Pharmacological and Toxicological Profiles.Oxid Med Cell Longev. 2022 Sep 5;2022:5628601. doi: 10.1155/2022/5628601. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36105486 Free PMC article. Review.
-
Increased interleukin-6 levels associated with malaria infection and disease severity: a systematic review and meta-analysis.Sci Rep. 2022 Apr 8;12(1):5982. doi: 10.1038/s41598-022-09848-9. Sci Rep. 2022. PMID: 35396564 Free PMC article.
-
IL-18 and IL-18 binding protein are related to disease severity and parasitemia during falciparum malaria.BMC Infect Dis. 2021 Oct 18;21(1):1073. doi: 10.1186/s12879-021-06751-y. BMC Infect Dis. 2021. PMID: 34663245 Free PMC article.
References
-
- World Health Organization. World malaria report 2017. Available at: http://wwwwhoint/malaria/publications/world-malaria-report-2017/en/2017. Accessed 14 December 2017.
-
- Hoffman SL, Oster CN, Mason C, et al. Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. J Immunol 1989; 142:1299–303. - PubMed
-
- Cohen S, McGregor IA, Carrington S Gamma-globulin and acquired immunity to human malaria. Nature 1961; 192:733–7. - PubMed